CORD BLOOD TRANSPLANT THERAPY

This adverse event was reported 85 times

These drugs are most commonly taken by patients reporting CORD BLOOD TRANSPLANT THERAPY:

# Drug Count
0 FLUDARABINE PHOSPHATE 25
1 CYCLOSPORINE 22
2 AZACITIDINE 18
3 VENETOCLAX 18
4 AZACITIDINE FOR 17
5 TACROLIMUS 16
6 METHOTREXATE 14
7 METHOTREXATE SODIUM 14
8 CYCLOPHOSPHAMIDE 13
9 CYCLOPHOSPHAMIDE FOR INJECTION 13
See all common drugs associated with CORD BLOOD TRANSPLANT THERAPY

CORD BLOOD TRANSPLANT THERAPY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM MONOFLUOROPHOSPHATE 1 0.0027
1 CHLOROTHIAZIDE 1 0.0008
2 TOLNAFTATE 1 0.0008
3 INTERFERON GAMMA-1B 1 0.0007
4 FLUDARABINE PHOSPHATE 25 0.0006
5 AZACITIDINE 18 0.0006
6 MICAFUNGIN SODIUM 3 0.0005
7 AMPICILLIN SODIUM AND SULBACTAM SODIUM 1 0.0004
8 VANCOMYCIN HYDROCHLORIDE 3 0.0004
9 VALPROATE SODIUM 7 0.0003
See all drugs enriched for association with CORD BLOOD TRANSPLANT THERAPY

CORD BLOOD TRANSPLANT THERAPY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interferon gamma [EPC] 1 0.0007
1 Echinocandin Antifungal [EPC] 3 0.0004
2 BCL-2 Inhibitor [EPC] 18 0.0003
3 CD33-directed Immunoconjugate [EPC] 1 0.0003
4 Osmotic Diuretic [EPC] 1 0.0002
5 Calcineurin Inhibitor Immunosuppressant [EPC] 22 0.0002
6 Tetracycline-class Antibacterial [EPC] 1 0.0001
7 Lipopeptide Antibacterial [EPC] 1 0.0001
8 Azole Antifungal [EPC] 14 0.0001
9 Alkylating Drug [EPC] 20 0.0001
See all drug classes enriched for association with CORD BLOOD TRANSPLANT THERAPY